Sector: MedicalGenentech, Inc. (NYSE: DNA)
Headlines
- FDA Calendar Extreme Trades: 85 Single Digit Stocks
Oct 13, 2009 12:34 PM | ACCP, APOL, CLDA, CRI, CRL, CYTX
- Dendreon (DNDN) Rises As New Board Members Are Appointed
Oct 12, 2009 02:05 PM | AGEN, DNA, DNDN
- The Next Big Thing In Health Care: How To Profit From Immunotherapy & Regenerative Medicine
Oct 07, 2009 03:27 PM | BBI, BMRN, BMY, CVM, CYTX, DNA
- SurModics, Inc. (SRDX) Signs Agreement With Genentech and Roche
Oct 07, 2009 12:27 PM | DNA, SRDX
- BioMed News Bytes: Dendreon, Chelsea, Cytori, Cephalon, OraSure, Genzyme, Lixte
Sep 24, 2009 07:06 PM | CAM, CEPH, CHTP, CYTX, DNA, DNDN
- BioMed News Bytes: BSD Medical, Provectus, Incyte, OncoMethylome
Sep 22, 2009 12:42 PM | DNA, INCY, NDN, PVCT
- Pressure BioSciences (NASDAQ: PBIO): A New Paradigm For Sample Processing
Sep 20, 2009 11:54 PM | AMGN, DNA, LLY, MON, NVS, PBIO
- Emerging Market Or Pharma
Aug 25, 2009 02:57 PM | AZN, DNA, GOOG, GSK, NVS, RHHBY
- Spotlight On: Biotech
Aug 09, 2009 03:11 PM | AAPL, AMGN, BIIB, BNT, BRL, CVD
- Catch These Stocks And You'll Never Have To Work Again
Jul 29, 2009 11:57 AM | BMY, DNA, MEDX, PFE
- Jury convicts N.J. man of southside Lebanon bank robbery
Nov 07, 2009 03:50 AM | DNA, MTB
- Carnegie Mellon exhibit blurs line between artist, tools
Nov 05, 2009 11:57 PM | DNA
- The News and Advance, Lynchburg, Va., Darrell Laurant Column: A Problem That Needs to Be Addressed
Oct 25, 2009 11:52 AM | DNA
- Catch Up on Tribune Watchdog Reporting: 10 Reports That Got Results
Oct 23, 2009 05:51 AM | DNA, WFMI
- MandT Reports 41% Increase in Profits for Third Quarter
Oct 21, 2009 11:53 AM | DNA, MTB, PBKS
- MandTreports 41% Increase in Profits for Third Quarter
Oct 21, 2009 07:53 AM | DNA, MTB, PBKS
- Novato Study Shows Downtown Business Mix Short on Retail
Oct 15, 2009 11:57 PM | DNA, WFMI
- Roche Deal Lifts SurModics Stock: Eden Prairie Firm Could Take in $200M
Oct 07, 2009 04:14 AM | DNA, JNJ, MRK, RHHBY, RX, SRDX
- OPINION: Rebuilding Las Vegas
Sep 20, 2009 12:54 PM | DNA
- EDITORIAL: Letters: Hinkle Column Marginalized Minorities
Sep 13, 2009 03:55 AM | DNA
- Genentech Announces Voluntary Withdrawal of Raptiva from the U.S. Market
Apr 08, 2009 04:33 PM | DNA
- FDA Advisory Committee Unanimously Recommends Accelerated Approval of Avastin for Previously Treated Brain Cancer (Glioblastoma)
Mar 31, 2009 03:35 PM | DNA
- Roche Completes Acquisition of Genentech
Mar 26, 2009 01:04 PM | DNA, RHHBY
- Roche Completes Tender Offer for Genentech
Mar 26, 2009 02:00 AM | DNA, RHHBY
- Zacks Analyst Blog Highlights: Vivo Participacoes, America Movil, TIM Participacoes, Amylin Pharmaceuticals, Inc. And Eli Lilly.
Mar 24, 2009 06:52 AM | AMGN, AMLN, AMX, DNA, LLY, TSU
- Capacity Crowd at 2009 Southeast Venture Conference Optimistic About Market - Mar 19 2009 6:53PM
Mar 19, 2009 06:53 PM | AMGN, DNA, FDX
- Capacity Crowd at 2009 Southeast Venture Conference Optimistic About Market - Mar 19 2009 2:52PM
Mar 19, 2009 02:52 PM | AMGN, DNA, FDX
- OSI Pharmaceuticals Submits Supplemental New Drug Application to the FDA for Tarceva as a First-Line Maintenance Therapy in Advanced Non-Small Cell Lung Cancer
Mar 19, 2009 02:01 AM | DNA, OSIP
- Zacks Industry Outlook Highlights: Roche, Genentech, Gilead Sciences and CV Therapeutics
Mar 13, 2009 07:17 AM | CVTX, DNA, GILD
- Over 80 Life Science Industry Exhibitors at the NYBA Annual Meeting
Mar 12, 2009 11:54 AM | ACOR, AMRI, ARE, DNA, OSIP, PFE
- Form 4 Yang Patrick Y For: Mar 26 (10K)
Apr 20, 2009 07:34 PM
- Form 4 Andreatta Robert E For: Mar 26 (10K)
Mar 31, 2009 04:20 PM
- Form 4 CLARK IAN T For: Mar 26 (10K)
Mar 31, 2009 04:20 PM
- Form 4 GENENTECH INC For: Mar 26 Filed by: SANDERS CHARLES A (10K)
Mar 31, 2009 04:20 PM
- Form 4 BOYER HERBERT W PH D For: Mar 26 (10K)
Mar 30, 2009 11:23 PM
- Form 4 REED DEBRA L For: Mar 26 (10K)
Mar 30, 2009 11:19 PM
- Form 4 EBERSMAN DAVID A For: Mar 26 (10K)
Mar 30, 2009 11:15 PM
- Form 4 LEVINSON ARTHUR D For: Mar 26 (10K)
Mar 30, 2009 11:11 PM
- Form 4 DESMOND HELLMANN SUSAN For: Mar 26 (10K)
Mar 30, 2009 11:10 PM
- Form 4 SCHELLER RICHARD H For: Mar 26 (10K)
Mar 30, 2009 11:10 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
DNA
|
Compare to S&P
|
| YTD |
14.28 %
|
32.85 %
|
| 4 Weeks |
9.64 %
|
3.04 %
|
| 12 Weeks |
14.28 %
|
26.83 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 21.62 %
|
|
EPS Growth in Last Year: 50.00 %
|
|
Sales Growth in Last Quarter: 8.65 %
|
|
Sales Growth in Last Quarter: 24.81 %
|
|
